Zomedica banks on canine diarrhea drugsDecember 19, 2016Zomedica Pharmaceuticals Corp. has started talks with the U.S. Food and Drug Administration on the company’s third proposed veterinary product: an oral suspension formulated for the treatment of canine diarrhea.
SPONSORED CONTENTYear-Round Tick Control is ImportantEmpower dog owners to protect their dogs with protection approved by the FDA for the prevention of Lyme infections in dogs as a direct result of killing black-legged ticks. + Learn More
